BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ecker B, Mcmillan M, Datta J, Dempsey D, Karakousis G, Fraker D, Drebin J, Mamtani R, Giantonio B, Roses R. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study. European Journal of Cancer 2016;69:135-41. [DOI: 10.1016/j.ejca.2016.09.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang S, Zhao R, Li Y, Han X, Liu Z, Ge W, Dong Y, Han W. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database. Sci Rep 2018;8:7940. [PMID: 29786691 DOI: 10.1038/s41598-018-26145-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
2 Mann K, Gilbert T, Cicconi S, Jackson R, Whelan P, Campbell F, Halloran C, Neoptolemos J, Ghaneh P. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. Langenbecks Arch Surg 2019;404:439-49. [PMID: 30972486 DOI: 10.1007/s00423-019-01779-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Zhou YY, Du XJ, Zhang CH, Aparicio T, Zaanan A, Afchain P, Chen LP, Hu SK, Zhang PC, Wu M, Zhang QW, Wang H. Comparison of three lymph node staging schemes for predicting the outcome in patients with small bowel adenocarcinoma: A population-based cohort and international multicentre cohort study. EBioMedicine 2019;41:276-85. [PMID: 30824384 DOI: 10.1016/j.ebiom.2019.02.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
4 de Bree E, Rovers KP, Stamatiou D, Souglakos J, Michelakis D, de Hingh IH. The evolving management of small bowel adenocarcinoma. Acta Oncologica 2018;57:712-22. [DOI: 10.1080/0284186x.2018.1433321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
5 Collard MK, Parc Y, Lefevre JH. Letter to the Editor: "Long-Term Outcomes of Pancreas-Sparing Duodenectomy for Duodenal Polyposis in Familial Adenomatous Polyposis Syndrome". J Gastrointest Surg 2020;24:2174-5. [PMID: 32671795 DOI: 10.1007/s11605-020-04736-x] [Reference Citation Analysis]
6 Lin YM, Chou CL, Kuo YH, Wu HC, Tsai CJ, Ho CH, Chen YC, Yang CC, Lin CW. Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant Therapy. Cancer Manag Res 2021;13:8037-47. [PMID: 34729022 DOI: 10.2147/CMAR.S328666] [Reference Citation Analysis]
7 Dai ZH, Wang QW, Zhang QW, Yan XL, Aparicio T, Zhou YY, Wang H, Zhang CH, Zaanan A, Afchain P, Zhang Y, Chen HM, Gao YJ, Ge ZZ. Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study. EBioMedicine 2020;60:102979. [PMID: 32980692 DOI: 10.1016/j.ebiom.2020.102979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Puccini A, Battaglin F, Lenz HJ. Management of Advanced Small Bowel Cancer. Curr Treat Options Oncol 2018;19:69. [PMID: 30397729 DOI: 10.1007/s11864-018-0592-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Augustin T, Moslim MA, Cengiz TB, El-Hayek K, Simon R, Bhatt A, Tang A, Burke CA, Matthew Walsh R. Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer. J Surg Oncol 2020;122:1132-44. [PMID: 33124067 DOI: 10.1002/jso.26131] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Panjwani S, Moore MD, Gray KD, Finnerty BM, Beninato T, Brunaud L, Fahey TJ, Zarnegar R. The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma. Ann Surg Oncol 2017;24:3617-23. [DOI: 10.1245/s10434-017-6064-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
11 Bouali M, Sylvestre K, Benghait H, El Bakouri A, El Hattabi K, Bensardi FZ, Fadil A. Small bowel adenocarcinoma a rare cause of upper gastrointestinal obstruction (a case report and literature review). Int J Surg Case Rep 2022;91:106763. [PMID: 35030405 DOI: 10.1016/j.ijscr.2022.106763] [Reference Citation Analysis]
12 Dong F, Xu L, Peng X, Xu T, Shen Y, Gao F, Wang X, Zhang X, Chen S, Zhang M, Zhong S, Ding Q. Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma. Jpn J Clin Oncol 2018;48:942-9. [PMID: 30137442 DOI: 10.1093/jjco/hyy121] [Reference Citation Analysis]
13 Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM, Datta J. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2017;24:3926-3933. [PMID: 28952140 DOI: 10.1245/s10434-017-6095-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
14 Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One 2018;13:e0200204. [PMID: 30096150 DOI: 10.1371/journal.pone.0200204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhu Z, Zhong F. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Duodenal Adenocarcinoma: A SEER Analysis. Cancer Invest 2020;38:543-8. [PMID: 33073637 DOI: 10.1080/07357907.2020.1824260] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Xie X, Zhou Z, Song Y, Dang C, Zhang H. Surgical Management and Prognostic Prediction of Adenocarcinoma of Jejunum and Ileum. Sci Rep 2017;7:15163. [PMID: 29123252 DOI: 10.1038/s41598-017-15633-w] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Gelsomino F, Balsano R, De Lorenzo S, Garajová I. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management. Current Oncology 2022;29:1223-36. [DOI: 10.3390/curroncol29020104] [Reference Citation Analysis]
18 Chen EY, Vaccaro GM. Small Bowel Adenocarcinoma. Clin Colon Rectal Surg 2018;31:267-77. [PMID: 30186048 DOI: 10.1055/s-0038-1660482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Khosla D, Dey T, Madan R, Gupta R, Goyal S, Kumar N, Kapoor R. Small bowel adenocarcinoma: An overview. World J Gastrointest Oncol 2022; 14(2): 413-422 [DOI: 10.4251/wjgo.v14.i2.413] [Reference Citation Analysis]